...
xtlb-img

XTL Biopharmaceuticals Ltd ADR, Common Stock

XTLB

NAQ

$1.485

-$0.08

(-5.11%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$8.53M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
14.86K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.00
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.76 L
$4.99 H
$1.485

About XTL Biopharmaceuticals Ltd ADR, Common Stock

XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases in Israel. Its lead drug candidate is hCDR1, a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. It has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was incorporated in 1993 and is headquartered in Ramat Gan, Israel. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameXTLBSectorS&P500
1-Week Return-7.94%-3.39%0.2%
1-Month Return-10.57%-1.92%2.72%
3-Month Return-36.12%-10.54%7.31%
6-Month Return-35.86%-4.47%10.44%
1-Year Return59.73%4.06%27.53%
3-Year Return-46.76%0.94%30.88%
5-Year Return23.89%36.67%89.21%
10-Year Return-87.22%102.87%199.95%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue69.00K28.00K1.47M(459.00K)-[{"date":"2019-12-31","value":4.71,"profit":true},{"date":"2020-12-31","value":1.91,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-31.31,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue-1.00K1.00K1.00K-[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Profit69.00K27.00K1.47M(460.00K)-[{"date":"2019-12-31","value":4.71,"profit":true},{"date":"2020-12-31","value":1.84,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-31.4,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Gross Margin100.00%96.43%99.93%100.22%-[{"date":"2019-12-31","value":99.78,"profit":true},{"date":"2020-12-31","value":96.22,"profit":true},{"date":"2021-12-31","value":99.71,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Operating Expenses842.00K948.00K1.03M880.00K765.00K[{"date":"2019-12-31","value":81.67,"profit":true},{"date":"2020-12-31","value":91.95,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":85.35,"profit":true},{"date":"2023-12-31","value":74.2,"profit":true}]
Operating Income(842.00K)(948.00K)(1.03M)(880.00K)(765.00K)[{"date":"2019-12-31","value":-84200000,"profit":false},{"date":"2020-12-31","value":-94800000,"profit":false},{"date":"2021-12-31","value":-103100000,"profit":false},{"date":"2022-12-31","value":-88000000,"profit":false},{"date":"2023-12-31","value":-76500000,"profit":false}]
Total Non-Operating Income/Expense(441.00K)(1.99M)1.47M(443.00K)(1.04M)[{"date":"2019-12-31","value":-30.02,"profit":false},{"date":"2020-12-31","value":-135.47,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-30.16,"profit":false},{"date":"2023-12-31","value":-71.14,"profit":false}]
Pre-Tax Income(1.35M)(782.00K)435.00K(1.35M)(1.78M)[{"date":"2019-12-31","value":-309.66,"profit":false},{"date":"2020-12-31","value":-179.77,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-309.89,"profit":false},{"date":"2023-12-31","value":-409.66,"profit":false}]
Income Taxes(69.00K)(166.00K)(1.47M)961.00K(167.89K)[{"date":"2019-12-31","value":-7.18,"profit":false},{"date":"2020-12-31","value":-17.27,"profit":false},{"date":"2021-12-31","value":-152.55,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-17.47,"profit":false}]
Income After Taxes(1.28M)(616.00K)1.90M(2.31M)(1.61M)[{"date":"2019-12-31","value":-67.23,"profit":false},{"date":"2020-12-31","value":-32.4,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-121.46,"profit":false},{"date":"2023-12-31","value":-84.91,"profit":false}]
Income From Continuous Operations(1.35M)(782.00K)435.00K(1.35M)(2.25M)[{"date":"2019-12-31","value":-309.66,"profit":false},{"date":"2020-12-31","value":-179.77,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-309.89,"profit":false},{"date":"2023-12-31","value":-516.32,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(1.28M)(616.00K)1.90M(2.31M)(1.78M)[{"date":"2019-12-31","value":-67.23,"profit":false},{"date":"2020-12-31","value":-32.4,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-121.46,"profit":false},{"date":"2023-12-31","value":-93.74,"profit":false}]
EPS (Diluted)(0.00)(0.01)0.24(0.33)(0.33)[{"date":"2019-12-31","value":-0.37,"profit":false},{"date":"2020-12-31","value":-2.68,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-135.19,"profit":false},{"date":"2023-12-31","value":-135.11,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

XTLB
Cash Ratio 10.49
Current Ratio 11.43

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

XTLB
ROA (LTM) -13.78%
ROE (LTM) -13.07%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

XTLB
Debt Ratio Lower is generally better. Negative is bad. 0.08
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.92

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

XTLB
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 3.15
EV/R 0.00
EV/Ebitda 9.78
PEG NM

FAQs

What is XTL Biopharmaceuticals Ltd ADR share price today?

XTL Biopharmaceuticals Ltd ADR (XTLB) share price today is $1.485

Can Indians buy XTL Biopharmaceuticals Ltd ADR shares?

Yes, Indians can buy shares of XTL Biopharmaceuticals Ltd ADR (XTLB) on Vested. To buy XTL Biopharmaceuticals Ltd ADR from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in XTLB stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of XTL Biopharmaceuticals Ltd ADR be purchased?

Yes, you can purchase fractional shares of XTL Biopharmaceuticals Ltd ADR (XTLB) via the Vested app. You can start investing in XTL Biopharmaceuticals Ltd ADR (XTLB) with a minimum investment of $1.

How to invest in XTL Biopharmaceuticals Ltd ADR shares from India?

You can invest in shares of XTL Biopharmaceuticals Ltd ADR (XTLB) via Vested in three simple steps:

  • Click on Sign Up or Invest in XTLB stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in XTL Biopharmaceuticals Ltd ADR shares
What is XTL Biopharmaceuticals Ltd ADR 52-week high and low stock price?

The 52-week high price of XTL Biopharmaceuticals Ltd ADR (XTLB) is $4.99. The 52-week low price of XTL Biopharmaceuticals Ltd ADR (XTLB) is $0.76.

What is XTL Biopharmaceuticals Ltd ADR price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of XTL Biopharmaceuticals Ltd ADR (XTLB) is

What is XTL Biopharmaceuticals Ltd ADR price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of XTL Biopharmaceuticals Ltd ADR (XTLB) is 3.15

What is XTL Biopharmaceuticals Ltd ADR dividend yield?

The dividend yield of XTL Biopharmaceuticals Ltd ADR (XTLB) is 0.00%

What is the Market Cap of XTL Biopharmaceuticals Ltd ADR?

The market capitalization of XTL Biopharmaceuticals Ltd ADR (XTLB) is $8.53M

What is XTL Biopharmaceuticals Ltd ADR’s stock symbol?

The stock symbol (or ticker) of XTL Biopharmaceuticals Ltd ADR is XTLB

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top